A randomized comparison of 4 doses of intracoronary adenosine in the assessment of fractional flow reserve

Zeitschrift fur Kardiologie

Volumn 92, Issue 8, 2003, Pages 627-632

  Casella, Gianni ^b   Rieber, Johannes ^a   Schiele, Thomas M ^a   Stempfle, Hans Ulrich ^a   Siebert, Uwe ^c   Leibig, Marcus ^a   Theisen, Karl ^a   Buchmeier, Ulrich ^a   Klauss, Volker ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAGGIORE HOSPITAL   (Italy)

^c HARVARD CENTER FOR RISK ANALYSIS   (United States)

Author keywords

Angioplasty; Coronary artery disease; Fractional flow reserve; Stenting

Indexed keywords

ADENOSINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIAGNOSTIC IMAGING; FEMALE; FRACTIONAL FLOW RESERVE; HEART CATHETERIZATION; HUMAN; INTRACORONARY INFUSION; MALE; MEDICAL INSTRUMENTATION; MICROCIRCULATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VASODILATATION;

ADENOSINE; ADULT; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; CORONARY VESSELS; DATA INTERPRETATION, STATISTICAL; FEMALE; HEART CATHETERIZATION; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; HYPEREMIA; INJECTIONS, INTRA-ARTERIAL; MALE; MICROCIRCULATION; MIDDLE AGED; VASODILATION; VASODILATOR AGENTS;

EID: 0041823851     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-003-0948-x     Document Type: Article

References (22)

1. Topol EJ, Nissen SE (1995) Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 92:2333-2342
2. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J (1992) Validation of a Doppler guidewire for intravascular measurement of coronary artery flow velocity. Circulation 85:1899-1911
3. Pijls NHJ, de Bruyne B, Peels K et al (1996) Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334:1703-1108
4. Casella G, Klauss V, Stempfle H-U, Mudra H (1999) Beyond morphology: new coronary physiologic approaches to interventions. G Ital Cardiol 29:174-181
5. van der Voort PH, van Hagen E, Hendrix G et al (1996) Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve. Cathet Cardiovasc Diagn 39:120-125
6. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxon DD (1990) Effects of adenosine on human coronary circulation. Circulation 82:1595-1606
7. Kern MJ, Deligonul U, Tatineni S, Serota H, Aguirre F, Hilton TC (1991) Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol 18:718-729
8. Jeremias A, Filardo SD, Whitbourn RJ, Kernoff RS, Yeung AC, Fitzgerald PJ, Yock P (2000) Effect of intravenous and intracoronary adenosine 5′-triphosphate as compared with adenosine on coronary flow and pressure dynamics. Circulation 101:318-323
9. Pijls NH, van Gelder B, van der Voort P et al (1995) Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 92:3183-3193
10. Pijls NH, van Son JA, Kirkeeide RL et al (1993) Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 87:1354-1367
11. Lansky AJ, Popma JJ (1999) Qualitative and quantitative angiography. In: Topol EJ et al (eds) Textbook of Interventional Cardiology. 3rd ed. WB Saunders, Philadelphia, pp 725-747
12. De Bruyne B, Bartunek J, Sys SU et al (1995) Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 92:39-46
13. Kern MJ, de Bruyne B, Pijls NH (1997) From research to clinical practice: current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory. J Am Coll Cardiol 30:613-620
14. Kern MJ, Donohue TJ, Aguirre FV et al (1995) Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements. J Am Coll Cardiol 25:178-187
15. Bech GJW, De Bruyne B, Pijls NHJ et al (2001) Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 103:2928-2934
16. De Bruyne B, Bartunek J, Sys SU et al (1996) Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation 94:1842-1849
17. Warltier DC, Gross GJ, Brooks HL (1981) Pharmacologic vs. ischemia-induced coronary artery vasodilation. Am J Physiol 240:767-774
18. Kern MJ, Deligonul U, Tatineni S et al (1991) Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol 18:718-729
19. Jeremias A, Whitbourn RJ, Filardo SD et al (2000) Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Am Heart J 140:651-657
20. Di Segni E, Higano ST, Rihal CS, Holmes Jr DR, Lennon R, Lerman A (2001) Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making. Cathet Cardiovasc Intervent 54:34-40
21. Bech GJ, Pijls NH, De Bruyne B et al (1999) Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation 99:883-888
22. Hanekamp CE, Koolen JJ, Pijls NH et al (1999) Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment. Circulation 99:1015-1021